Back to top
more

Valneva (VALN)

(Delayed Data from NSDQ)

$7.75 USD

7.75
1,499

+0.01 (0.10%)

Updated Apr 24, 2024 11:59 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (152 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for VALN

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

Valneva SE Sponsored ADR [VALN]

Reports for Purchase

Showing records 1 - 20 ( 42 total )

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 1

03/21/2024

Company Report

Pages: 6

FY23 Results; Updated FY24 Guidance; Ixchiq U.S. Commercial Launch Underway

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 25.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 2

02/29/2024

Daily Note

Pages: 3

Chikungunya Vaccine Ixchiq Receives ACIP Recommendation

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 10.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 3

02/15/2024

Company Report

Pages: 5

2023 Revenue and YE23 Cash Position Announced; 2024 Revenue Guidance Above Consensus But Slightly Below Our Estimate

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 10.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 4

02/05/2024

Company Report

Pages: 5

Priority Review Voucher Sold For $103M

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 10.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 5

01/10/2024

Daily Note

Pages: 3

First Participant Dosed in Phase 2 Pediatric Trial for Chikungunya

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 10.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 6

01/05/2024

Company Report

Pages: 5

Model Update

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 5.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 7

12/05/2023

Daily Note

Pages: 3

Phase 3 VALOR Trial of VLA15 For Lyme Disease Completes Recruitment

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 5.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 8

12/04/2023

Daily Note

Pages: 3

Valneva Reports Positive 24-Month Antibody Persistence Data For Ixchiq

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 5.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 9

11/27/2023

Daily Note

Pages: 3

EMA Accepts Chikungunya Vaccine MAA for Accelerated Assessment

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 5.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 10

11/22/2023

Company Report

Pages: 6

Optimized Entry and Exit Levels for VALN 112223

Provider: Stock Traders Daily

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 11

11/13/2023

Company Report

Pages: 6

Highlights From Company Call Regarding Chikungunya Vaccine Approval; Adolescent Data Positive

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 12.50

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 12

11/10/2023

Company Report

Pages: 6

3Q23 Results; VLA1553 (Now Ixchiq) Approved by the FDA for Chikungunya; Raising Price Target

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 12.50

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 13

10/26/2023

Daily Note

Pages: 3

Submission of VLA1553 Chikungunya Vaccine Marketing Application to EMA

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 5.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 14

09/27/2023

Company Report

Pages: 6

1H23 Results; Chikungunya Vaccine PDUFA Action Date at End of November 2023

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 12.50

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 15

09/25/2023

Daily Note

Pages: 3

Valneva Announces New Ixiaro Supply Agreement With the U.S. DoD

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 5.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 16

09/07/2023

Daily Note

Pages: 3

Positive Pediatric and Adolescent Phase 2 Booster Results for VLA15

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 5.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 17

08/29/2023

Daily Note

Pages: 3

Health Canada Accepts VLA1553 Chikungunya Vaccine Marketing Application

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 5.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 18

08/28/2023

Daily Note

Pages: 3

Valneva Reports Positive Phase 3 Initial Safety Data For VLA1553 in Adolescents

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 5.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 19

08/14/2023

Daily Note

Pages: 3

VLA1553 Chikungunya Vaccine Candidate PDUFA Action Date Extension From August to November 2023

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 5.00

Research Provided by a Third Party

Company: Valneva SE Sponsored ADR

Industry: Medical - Products

Record: 20

05/30/2023

Daily Note

Pages: 3

Chikungunya Vaccine VLA1553 Filed For Approval in Canada

Provider: H.C. Wainwright & Co., Inc.

Analyst: WHITE E

Price: 5.00

Research Provided by a Third Party